跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,666 条关于
“Ananda Pharma”
全部
10,666
临床试验
4,772
药物
1,164
机构
1,302
资讯
3,428
去年
Ananda Pharma Achieves GMP Manufacturing Milestone for MRX1 Pain Treatment Program
9个月前
Ananda Pharma Exits Public Markets and NHS Epilepsy Trial to Focus on Pain Treatment Pipeline
3个月前
Ananda Pharma Publishes Clean Phase I Safety Data for MRX1 CBD Oral Solution, Paving Way for Phase II Pain Trials
4个月前
Cannabis Drug Companies Eye IPOs and Private Funding Following U.S. Rescheduling to Schedule III
去年
Ananda Developments Enters Phase III Trials for Cannabis-Based Epilepsy Treatment
去年
Ananda Developments' Cannabinoid Medicines to be Used in NHS Epilepsy Trials
去年
Ananda Developments Advances Cannabinoid Medicines in Phase III Epilepsy Trials
去年
Ananda Developments Initiates Phase 1 Trial of CBD Compound MRX1 in Australia
去年
Ananda Developments Appoints Professor Marie Fallon to Scientific Advisory Board
10个月前
Ananda Scientific Partners with Benta to Advance PTSD Treatment Development in Europe and MENA
第 1 页,共 343 页
上一页
下一页